Radius Ventures
Overview
Radius Ventures is a venture capital firm that invests in growth equity and expansion-stage health and life sciences companies . The firm is led by a seasoned group of investment professionals with collective experience across all major sectors of the industry, including medical devices, diagnostics, biopharmaceuticals, life science tools, healthcare services and healthcare information technology . Radius takes an active approach with each portfolio company by providing intellectual capital, strategic guidance and access to key industry relationships that accelerate growth and increase the odds of success .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Endoluminal Solutions Inc. | May 2019 | Series I | Co-investor |
| Perceptive | Feb 2016 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Key People
Jordan Davis
Co-Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Radius Ventures based?
Radius Ventures is headquartered in New York City, New York, United States.
When was Radius Ventures founded?
Radius Ventures was founded in 1997.
How many portfolio companies does Radius Ventures have?
Radius Ventures has 6 portfolio companies in Caplight's dataset.
What are some companies in Radius Ventures's portfolio?
Portfolio companies visible on Caplight include Endoluminal Solutions Inc., Perceptive.
What was Radius Ventures's most recent investment shown here?
Radius Ventures's most recent investment in this portfolio sample was in Endoluminal Solutions Inc. in 2019.
What sectors does Radius Ventures focus on?
Radius Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech.
What company stages does Radius Ventures focus on?
Radius Ventures typically invests at the Late stage.
What is Radius Ventures's AUM?
Radius Ventures's assets under management are estimated between $100.0M and $250.0M.